Jonathan Levine, MBA, PhD

Interpace Diagnostics

Poster(s):

• P2882 - New, Under-Recognized Genomic Alterations Enable Early Identification of High-Risk Pancreatic Cysts Likely to Progress to Malignancy
  Tuesday, October 24, 2023

  10:30 AM – 4:00 PM PT